Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
coronavirus
archive
covid-19
aldehyde
aldeyra therapeutics
allergic conjunctivitis
artificialintelligence
boston
boston blog main
boston top stories
clinical trials
data
drugs
dry eye disease
health/life sciences
healthcare
hydroxychloroquine
life sciences
machinelearning
national blog main
reproxalab
research
science
sjogren-larsson syndrome
study
trump
uw medicine
What
medicine
6
×
positive
6
×
covid
drug
fda
new
results
treatment
addressed
aimed
aldeyra
answers
best
big
budding
ceo
chief
chronic
clinical
closer
cold
commissioner
conduct
coronavirus
cost
data
diagnosis
disclosed
disorders
early
experiencing
eye
fighting
filing
finding
following
gilead
gottlieb
hasten
hope
Language
unset
Current search:
positive
×
medicine
×
@slashgear.com
3 years ago
Psilocybin study offers hope for chronic migraine sufferers
@bgr.com
3 years ago
Former FDA chief says this is the best coronavirus medicine Trump can get right now
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@geekwire.com
3 years ago
UW Medicine to conduct clinical trial for hydroxychloroquine with COVID patients
@DAMGRU
4 years ago
#Data science, #artificialintelligence, and #machinelearning: Opportunities for laboratory medicine and the value of positive regulation https://www.sciencedirect.com/science/article/pii/S0009912018311974?via%3Dihub
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug